Navigation Links
Questcor to Commence Phase 2 Study of Acthar for ALS
Date:7/24/2013

l need such as ALS. Questcor also has agreed to acquire certain international rights for Synacthen® (tetracosactide) and Synacthen Depot®, and has licensed the right to develop and seek FDA approval for these products in the United States.  For more information about Questcor, please visit www.questcor.com.  For more information about Acthar, including important safety information, please visit www.acthar.com.

Note: Except for the historical information contained herein, this press release contains forward-looking statements that have been made pursuant to the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "believes," "continue," "could," "estimates," "expects," "growth," "intent," "may," "plans," "potential," "should," "substantial," "will," or "would" or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the following:

  • Research and development risks, including risks associated with Questcor's work in the area of ALS;
  • Our reliance on Acthar for substantially all of our net sales and profits;
  • The lack of patent protection for Acthar; and the possible FDA approval and market introduction of competitive products;
  • The results of any pending or future litigation, investigations or claims, including with respect to the investigation by the United States Attorney's Office for the Eastern District of Pennsylvania regarding the Company's promotional practices and litigation brought by certain
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Questcor to Report Second Quarter Financial Results on July 30, 2013
2. Questcor to Initiate Pilot Commercialization Effort In Pulmonology for Symptomatic Sarcoidosis
3. Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
4. Questcor Adds Angus C. Russell to Board of Directors
5. Questcor Reports First Quarter Financial Results
6. Questcor to Report First Quarter Results on April 30, 2013
7. Questcor Reports Fourth Quarter and Full Year 2012 Results
8. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
9. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
10. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
11. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015  Frequentz Inc., a global leader ... white paper to help the pharmaceutical industry understand the ... Chain Security Act (DSCSA). The white paper, "From Lot-based ... GS1 EPCIS Standard(s) and Implementation Plan rollout, ... product tracing requirements that need to occur between now ...
(Date:3/31/2015)... MALVERN, Pa. , March 31, 2015  SCILEX ... commercialization of products focused on the treatment of pain, ... Tokyo Japan ), a member of ITOCHU ... one of the three leading sogo shosha (general trading ... a strategic investment in SCILEX.  ICF has worked closely ...
(Date:3/31/2015)... PARK, N.C. , March 31, 2015  Dr. ... will be attending the World Orphan Drug Congress in April ... regulatory approval process and orphan drugs below: ... (DTAB) has recommended to the Ministry of Health that if ... country, marketing authorization can be obtained in India ...
Breaking Medicine Technology:Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 2Frequentz Releases White Paper Addressing DSCSA's Current & Future Impact 3SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2
(Date:4/1/2015)... 2015 San Francisco based sustainable medical ... medical charity, Operation Smile, have launched a ... Campaign Details: RxOrganics is generously donating 5% of ... Operation Smile throughout 2015. RxOrganics has committed to an ... that every order placed online through the Rxmedical shop ...
(Date:4/1/2015)... 2015 Results are in for the ... featured 11 new homes from across the state exemplifying ... utilized innovative building techniques and new technology intended to ... Associates, Inc. (SWA) provided sustainability consulting services for 4 ... including the first- and third-place winners. , The Benker ...
(Date:4/1/2015)... Poisonous plants (poison ivy, oak and ... recent years, increasing significantly in number and rash-causing potency. ... to poison plants (according to the American Academy of ... summer adventures in nature, they should be aware that ... greater than ever. This year, Ivarest adds a new ...
(Date:3/31/2015)... April 01, 2015 Bon Secours New ... to the Schervier Nursing Care Center family last week. ... the Queen in Yonkers which is scheduled to close ... SC, president of the Sisters of Charity of New ... of directors to place their Sisters at Schervier Nursing ...
(Date:3/31/2015)... As the demand for optimized mobile ... have a mobile-friendly website online sometime during the month ... Fitness’ continued commitment to bring the best and most ... of the same great fitness information at http://www.chunkfitness.com ... easier to read while browsing on a mobile device. ...
Breaking Medicine News(10 mins):Health News:RxOrganics Forges Unique Partnership to Bring More Smiles to Underserved Global Heath Communities 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2
... today between the National Institute of Health & Family ... transfer of technology developed by the NIHFW in ... Kits for Testing Sperm Functions. The up scaling of ... by NRDC for commercialization. Prof. Deoki Nandan, Director, NIHFW ...
... The Chandigarh administration, planning to make the city 'smoke-free' from ... ,At a meeting of the committee set up to ... city, it was decided to empower police officials of the ... public places by recovering the penalty from the offender on ...
... business unit of India's Wipro Ltd with presence in ... eco-friendly range of desktops and laptops that aim ... new range of products, christened Wipro GreenWare, is compliant ... ,The $3-billion IT bellwether has set up an e-waste ...
... Angelina Jolie insists that vanity is not the reason behind her ... grief over her mothers death is the real reason. ... new movie A Mighty Heart that the reason shes lost weight ... her mother Marcheline Bertrand, who died of ovarian cancer in January, ...
... of the lower half of the body could get a ... cell treatment being offered by a hospital here. ... of making paraplegics walk again and managed to instill many ... ,The Lifeline Institute of Stem Cell Therapy ...
... Welfare, Dr. Anbumani Ramadoss inaugurated today a videoconference system for ... This is the first time that the counseling is ... ,DGHS is entrusted with the responsibility of allotting ... India quota of PG courses (MD/MS, PG Diploma & MDS) ...
Cached Medicine News:Health News:National Institute Of Health & Family Welfare To Commercialize Its Products 2Health News:Stem Cell Treatment Offers Hope for Paralysis Patients 2Health News:Stem Cell Treatment Offers Hope for Paralysis Patients 3Health News:Counseling For Medical And Dental Seats Allotment Through Videoconferencing 2
... Rapid exchange thrombectomy never ... with tortuous anatomy in mind, ... cut shaft, soft tip and ... trackability, and pushability. Glide in ...
... Radiometer's 1st automatic is an automated ... samplers and IT to reduce the steps ... operator safety, and minimize errors. The 1st ... arterial sampler, FLEXLINK software, and FLEXQ automatic ...
... three software components that comprise the ... software components comprise the SmartPill GI ... SmartPill Data Receiver software and SmartPill ... integrated and indispensable parts of the ...
... is the new second-generation application software for ... ,This software release includes a range ... efficiency and userfriendliness. Included are automatic tools ... Blood Indicator (SBI) which highlights images that ...
Medicine Products: